Vaccinations; Vaccine Transparency and Informed Consent Act; purpose; transparency and disclosure requirements; informed consent standards; civil penalties; confidentiality of records; severability; effective date.
HB1079 creates the “Vaccine Transparency and Informed Consent Act” and sets out new disclosure and consent requirements before any vaccine is administered in Oklahoma. The bill requires health care providers to give patients a written document in advance that lists vaccine ingredients, summarizes testing and development, and describes known and potential health and safety risks, including clinical trial data, post-market surveillance information, ethical considerations such as fetal tissue cell lines or animal-derived components, exemption availability under state law, and information about the federal Vaccine Injury Compensation Program.
The measure also requires providers to give patients time to review the materials, answer questions in a clear manner, and obtain written informed consent acknowledging receipt of the information and the patient’s choice to accept, decline, or defer vaccination. Providers must keep signed consent forms in the medical record for at least seven years. The bill establishes civil penalties for noncompliance, allows complaints to licensing boards and civil lawsuits, and requires confidentiality of the records under HIPAA and other privacy laws. It would take effect November 1, 2025.
If enacted, HB1079 would add a new statutory framework in Title 63 governing vaccine disclosures and informed consent, imposing specific pre-vaccination documentation duties on health care providers and institutions. It would also create enforcement mechanisms through civil penalties, professional discipline, and potential license suspension or revocation, while preserving patient access to complaints and damages claims. The bill would affect vaccination practices, medical record retention, and provider liability across Oklahoma.
The available context shows the bill was introduced and referred to the House Public Health Committee, but there are no recorded committee transcripts or votes in the provided materials. As a result, there is no documented floor or committee sentiment to summarize from the record here. Based on the bill text alone, the measure appears designed to emphasize patient choice and disclosure, while also signaling a more stringent regulatory approach to vaccination practices.
The main points of contention likely center on the scope and burden of the required disclosures, especially the mandate to provide extensive information on ingredients, trial data, adverse events, exemptions, and ethical issues before vaccination. Supporters would likely frame the bill as strengthening informed consent and patient autonomy, while opponents may view it as duplicative of existing federal vaccine information requirements, potentially confusing for patients, and burdensome for providers. The civil penalties and possible professional discipline provisions are also likely to be controversial because they create significant compliance and liability exposure for health care providers.